Drugs Made In America Acquisition II (DMIIR) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.08, +42.86% vs the prior close of $0.05.
- Volume 645 shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Bold Eagle Acquisition (BEAG)Southport Acquisition Corp. II (PORT-UN)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Archimedes Tech SPAC Partners II (ATII)Frazier Life Sciences Acquisition Corp. II (FLSC)
DMIIR jumps 42.9% to $0.08. Closed at $0.08, +42.86% vs the prior close of $0.05. Day range $0.05–$0.08, opened at $0.05.
DMIIR daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — DMIIR jumps 42.9% to $0.08
- Closed at $0.08, +42.86% vs the prior close of $0.05. Day range $0.05–$0.08, opened at $0.05.
- Volume was 645 shares, 0.7x its 50-day average of 930.
- 52-week range $0.05–$0.08; today's close sits at 100% of that range, at a new 52-week high.
DMIIR bull case vs bear case (from the data)
- Latest fiscal-year net income: profit of $4.19M.
- Insiders made 8 open-market purchases in the last 12 months.
- High volatility: average daily move of 42.9% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
DMIIR latest news & SEC filings
Every SEC filing by or about DMIIR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $4.40M (prior year -$38.07K) (swung to profit vs Jun 30, 2025)
Things to know before you trade DMIIR
- How much it moves: over the last 20 sessions the average daily move was 42.86% (largest 42.9%). That is a volatile stock.
- Liquidity: about 788 shares (≈$59) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.08 vs a range of $0.05–$0.08 (100% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 8 sales; latest: Made In America Acquisition Ii Llc Drugs bought 700,000 shares on Sep 26, 2025.
- Latest filings: 10-Q Aug 14, 2026; 10-Q May 14, 2026; 8-K Apr 28, 2026.
- Listing: Nasdaq · industry: Blank Checks.
DMIIR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.05 | 0.08 | 0.05 | 0.08 | 645 |
| Oct 16, 2026 | 0.05 | 0.05 | 0.05 | 0.05 | 930 |
About Drugs Made In America Acquisition II
Drugs Made In America Acquisition II (DMIIR) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in NEW YORK, NY. Fiscal year ends December 31. SEC CIK 2040475.
DMIIR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Catherine Do | Director | Oct 17, 2025 |
| Sridhar G. Prasad | Director | Oct 1, 2025 |
| Myron W. Shulgan | Director | Oct 2, 2025 |
| Lynn Stockwell | CEO and Exe. Chair of Board | Oct 1, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | Oct 1, 2025 |
| Glenn C. Worman | CFO | Oct 1, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
DMIIR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $4.19M | — | $-1.02M |
Latest balance sheet: total assets $514.10M, total liabilities $18.14M, cash $174.97K (as of Jun 30, 2026).
DMIIR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Bold Eagle Acquisition (BEAG)Southport Acquisition Corp. II (PORT-UN)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Archimedes Tech SPAC Partners II (ATII)Frazier Life Sciences Acquisition Corp. II (FLSC)Innventure (INV)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on DMIIR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.